Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases
Abstract The development of brain metastases (BMs) in breast cancer (BC) patients remains a challenging complication. Current clinical practice guidelines recommend local treatment of BMs without changing systemic therapy (CST) in patients with stable extracranial disease. We retrospectively investi...
Enregistré dans:
Auteurs principaux: | , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b13d01d1e9f04a52984ccf0fe8205030 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|